LVGO News
Archived Headlines
- Chronic illness management platform Livongo Health increases proposed IPO range to $24 to $26 07/22/19
- US IPO Week Ahead: The IPO marathon continues in a 7-deal week featuring health-tech 07/19/19
- Chronic illness management platform Livongo sets terms for $230 million IPO 07/15/19
- Chronic illness management platform Livongo Health files for a $100 million IPO 06/28/19
US IPO Week Ahead: No IPOs in the shortened holiday week
While no companies are scheduled to go public in the week ahead, several companies could join the IPO calendar. Potential Launches include health clinic chain One Medical (ONEM), DTC mattress unicorn Casper (CSPR), and...read more
US IPO Week Ahead: IPO filings heat up amid annual August break
The IPO market’s annual August break is here, with no companies scheduled to go public in the week ahead, save for one holdover from last week that may price: Chinese AR play WiMi Hologram (WIMI). The summer slowdown is almost over, and...read more
US IPO Weekly Recap: Health-tech tops 8-IPO week
Eight companies and two SPACs entered the public market this week. Health and tech companies Health Catalyst, Castle Biosciences, and Livongo dominated while solar energy installer Sunnova and sporting events company Wanda Sports Group fell flat.read more
Chronic gain: Livongo prices upsized IPO above the revised range at $28
Livongo Health, which provides a chronic condition management platform to self-insured employers, raised $355 million by offering 12.7 million shares at $28, above the upwardly revised range of $24 to $26. Livongo offered 2.0 million shares more than it...read more